Stabilization of asthma mortality

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 4, 1997, Pages 347-354

  Sly, R Michael ^a,b   O'Donnell, Regina ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; BIOSTATISTICS; HEALTH CARE UTILIZATION; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0030906513     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63195-X     Document Type: Article

References (66)

1. National Asthma Education Program Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute. Bethesda, US Dept Health and Human Services, Pub No 91-3042, August, 1991.
2. US Department of Health, Education, and Welfare. Vital Statistics of the United States, 1950-60.
3. Sly RM. Increases in deaths from asthma. Ann Allergy 1984;53:20-5.
4. Sly RM. Changing asthma mortality. Ann Allergy 1994;73:259-68.
5. Klebba AJ, Scott JH. Estimates of selected comparability ratios based on dual coding of 1976 death certificates by the eighth and ninth revisions of the International Classification of Diseases. Hyattsville, MD: National Center for Health Statistics, DHEW Pub No (PHS) 80-1120, vol 28, No 11, Suppl, Feb 29, 1980.
6. US Dept of Health and Human Services. Advance report of final mortality statistics, 1994. NCHS Monthly Vital Statistics Report 45 (3) suppl, Sep 30, 1996.
7. US Dept Health, Education, and Welfare. Vital Statistics of the United States - 1980, VoI II, Mortality, Part A, Section 7, p 16.
8. British Thoracic Society. Accuracy of death cetificates in bronchial asthma. Thorax 1984;39:505-9.
9. Barger LW, Vollmer WM, Felt RW, Buist AS. Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy 1988;60: 31-9.
10. Granady L, Sly RM, O'Donnell R. Association of prevalence with morbidity and mortality from asthma [Abstract]. Ann Allergy 1994;72:59.
11. Yunginger JW, Reed CE, O'Connell EJ, et al. A community-based study of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis 1992;146:888-94.
12. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989;64: 1452-6.
13. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-1986. Br Med J 1990;300:1306-10.
14. Mitchell EA. Increasing prevalence of asthma. NZ Med J 1983;96:463-4.
15. Shaw RA, Crane J, O'Donnell TV. Prevalence of asthma in children Br Med J 1990;300:1652-3.
16. Peat JK, Toelle BG, Gray EJ, et al. Prevalence and severity of childhood asthma and allergic sensitization in seven climatic regions of New South Wales. Med J Australia 1995;163: 22-6.
17. Haahtela T, Lindholm H, Bjorksten F, et al. Prevalence of asthma in Finnish young men. Br Med J 1990;301: 226-8.
18. Norrman E, Rosenhall L, Nystrom L, et al. High prevalence of asthma and related symptoms in teenagers in Northern Sweden. Eur Respir J 1993; 6:834-9.
19. Sacher Y, Laor A, Danon YL. Longitudinal study on the prevalence of asthma among Israeli young adults. Israel J Med Sci 1994;30:564-72.
20. Kivity S, Shochat Z, Bressler R, et al. The characteristics of bronchial asthma among a young adult population. Chest 1995;108:24-7.
21. Sporik R, Holgate ST, Platts-Mills TAE, et al. Exposure to house dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med 1990;323:502-7.
22. Weitzman M, Gortmaker S, Sobol A. Racial, social, and environmental risks for childhood asthma. Am J Dis Child 1990;144:1189-94.
23. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of two years. Clin Exp Allergy 1993;23:504-11.
24. Infante-Rivard C. Childhood asthma and indoor environmental risk factors. Am J Epidemiol 1993;137:834-44.
25. Phelan PD. Asthma in children: epidemiology [Editorial]. Br Med J 1994; 308:1584-5.
26. Strunk RC, Mrazek DA, Fuhrmann GSW, LeBrecque JF. Physiologic and psychological characteristics associated with deaths due to asthma in childhood. JAMA 1985;254:1193-8.
27. Rea HH, Scragg R, Jackson R, et al. A case control study of deaths from asthma. Thorax 1986;41:833-9.
28. Sears MR, Rea HH, Beaglehole R, et al. Asthma mortality in New Zealand: a two year national study. NZ Med J 1985;98:271-5.
29. Rea HH, Sears MR, Beaglehole R, et al. Lessons from the national asthma mortality study: circumstances surrounding death. NZ Med J 1987;100: 10-3.
30. Robertson CF, Rubinfeld AR, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Australia 1990;152:511-7.
31. O'Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324: 359-63.
32. Joseph KS, Biais L, Ernst P, Suissa S. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. Br Med J 1996;312:79-83.
33. Levenson T, Greenberger PA, Donoghue ER, Lifschultz BD. Asthma deaths confounded by substance abuse. An assessment of fatal asthma. Chest 1996;110:604-10.
34. Imai M, Yoshida K, Kitabatake M. Mortality from asthma and chronic bronchitis associated with changes in sulfur oxides air pollution. Arch Environ Health 1986;41:29-35.
35. Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma. Am Rev Respir Dis 1992;146: 76-81.
36. Sears MR, Rea HH, Rothwell RPG, et al. Asthma mortality: comparison between New Zealand and England. Br Med J 1986;293:1342-5.
37. Sears MR. Why are deaths from asthma increasing? Eur J Respir Dis 1986;69(suppl 147):175-81.
38. Sly RM. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs. Ann Allergy 1994;73:439-43.
39. Wong CS, Pavord ID, Williams J, et al. Bronchodilator, cardiovascular and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990;336:1396-9.
40. Grainger G, Woodman K, Pearce N, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991; 46:105-11.
41. Spitzer WO, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
42. Woodman K, Pearce N, Beasley R, et al. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study. Clin Pharmacol Ther 1992;51:566-71.
43. Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268:3462-4.
44. Keating G, Mitchell EA, Jackson R, et al. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J 1984;289:348-51.
45. Haas JF, Staudinger HW, Schuijt C. Asthma deaths in New Zealand [Letter]. Br Med J 1992;304:1634.
46. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Pub Health 1992;82:59-65.
47. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969-1991. N Engl J Med 1994;331: 1542-6.
48. Coultas DB, Gong Jr H, Grad R, et al. Respiratory diseases in minorities of the United States. Am J Respir Crit Care Med 1993;149:S93-S131.
49. Dawson B, Horobin G, Illsley R, Mitchell R. A survey of childhood asthma in Aberdeen. Lancet 1969;i: 827-30.
50. Strachan DP, Anderson HR, Limb ES, et al. A national survey of asthma prevalence, severity, and treatment in Great Britain. Arch Dis Child 1994;70: 174-8.
51. Mielck A, Reitmeir P, Wjst M. Severity of childhood asthma by socioeconomic status. Int J Epidemiol 1996;25: 388-93.
52. Halfon N, Newachek PW. Childhood asthma and poverty: differential impacts and utilization of health services. Pediatr 1993;91:56-61.
53. Finkelstein JA, Brown RW. Schneider LC, et al. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatr 1995;95:389-94.
54. Wilson JW, Jenkins CR. Asthma mortality: where is it going? Med J Austr 1996;164:391-3.
55. Comino EJ, Mitchell CA, Bauman A, et al. Asthma management in eastern Australia, 1990 and 1993. Med J Austr 1996;164:403-6.
56. Lantner RR, Ros SP. Emergency management of asthma in children: impact of NIH guidelines. Ann Allergy Asthma Immunol 1995;74:188-91.
57. Emerman CL, Cydulka RK, Skobeloff E. Survey of asthma practice among emergency physicians. Chest 1996; 109:708-12.
58. Squillace SP, Shaughnessy AF, Slawson DC. The allergist as an educator: an evolving relationship between specialty and primary care clinicians [Editorial]. Ann Allergy Asthma Immunol 1996;77:341-4.
59. Terr AI, Bloch DA. Trends in asthma therapy in the United States: 1965-1992. Ann Allergy Asthma Immunol 1996;76:273-81.
60. Leone A Jr. Medical practice guidelines are useful tool in litigation. Med Malpractice Law Strategy 1993;10(6): 1,4-6.
61. Iglehart JK. Health policy report. Physicians and the growth of managed care. N Engl J Med 1994;331: 1167-71.
62. Weiner JP. Forecasting the effects of health reform on US physician workforce requirement: evidence from HMO staffing patterns. JAMA 1994; 272:222-30.
63. Sorum PC. Ethical decision making in managed care. Arch Intern Med 1996; 156:2041-5.
64. Sly RM. Managed care - the key to quality of management of asthma. [Editorial]. Ann Allergy Asthma Immunol 1996;76:161-3.
65. Rea HH, Scragg R, Jackson R, et al. A case-control study of death from asthma. Thorax 1986;41:833-9.
66. Dodge R, Cline MG, Burrows B. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. Am Rev Respir Dis 1986;133:981-6.